Clinical trials: Skin Graft

Atopic Dermatitis

Targeted Investigation of Microbiome Elimination

• Terminated
• Age: 18 to 80 years
• Phase 1
• Results posted

The purpose of this study is to examine the pharmacokinetics or survival of new product containing commensal infection fighting bacteria, on the skin of patients with Atopic Dermatitis (AD), after a single application.

Trial name

TIME-1 (NCT05177328)

Testing

S. hominis A 9 Product

Where

United States

Volunteers

21 people

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)